Targeting Inflammation in Acne: Current Treatments and Future Prospects

Am J Clin Dermatol. 2023 Sep;24(5):681-694. doi: 10.1007/s40257-023-00789-1. Epub 2023 Jun 16.

Abstract

Acne is a common, chronic inflammatory condition affecting millions of people worldwide, with significant negative impact on quality of life and mental health. Acne is characterized by comedones, inflammatory papules, pustules, and nodulocystic lesions, with long-lasting sequelae including scarring and dyspigmentation, the latter of which is more common in skin of color. The four main pillars of acne pathophysiology include alteration of sebum production and concentration, hyperkeratinization of the follicular unit, Cutibacterium acnes strains, and an inflammatory immune response. Newer research has provided greater insight into these pathophysiologic categories. This greater understanding of acne pathogenesis has led to numerous new and emerging treatment modalities. These modalities include combinations of existing treatments, repurposing of existing agents historically used for other conditions, new topical treatments, novel antibiotics, topical and oral probiotics, and various procedural devices. This article will provide an overview of emerging treatments of acne and their link to our current and improved understanding of acne pathogenesis.

MeSH terms

  • Acne Vulgaris* / drug therapy
  • Acne Vulgaris* / etiology
  • Administration, Topical
  • Anti-Bacterial Agents / therapeutic use
  • Humans
  • Inflammation / drug therapy
  • Quality of Life*
  • Skin / pathology

Substances

  • Anti-Bacterial Agents